Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
Sign Up to like & getrecommendations! Published in 2019 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofz375
Abstract: Abstract Background Letermovir is a novel cytomegalovirus antiviral that is approved for prophylaxis in hematopoietic stem cell transplantation recipients Methods After obtaining informed consent, letermovir prophylaxis was started in a patient with a presumed late-onset… read more here.
Keywords: immunodeficiency; resistant cytomegalovirus; letermovir resistant; letermovir ... See more keywords